Literature DB >> 11751374

Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile.

S V Allander1, N N Nupponen, M Ringnér, G Hostetter, G W Maher, N Goldberger, Y Chen, J Carpten, A G Elkahloun, P S Meltzer.   

Abstract

Gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumors of the digestive tract, are believed to arise from the interstitial cells of Cajal. GISTs are characterized by mutations in the proto-oncogene KIT that lead to constitutive activation of its tyrosine kinase activity. The tyrosine kinase inhibitor STI571, active against the BCR-ABL fusion protein in chronic myeloid leukemia, was recently shown to be highly effective in GISTs. We used 13,826-element cDNA microarrays to define the expression patterns of 13 KIT mutation-positive GISTs and compared them with the expression profiles of a group of spindle cell tumors from locations outside the gastrointestinal tract. Our results showed a remarkably distinct and uniform expression profile for all of the GISTs. In particular, hierarchical clustering of a subset of 113 cDNAs placed all of the GIST samples into one branch, with a Pearson correlation >0.91. This homogeneity suggests that the molecular pathogenesis of a GIST results from expansion of a clone that has acquired an activating mutation in KIT without the extreme genetic instability found in the common epithelial cancers. The results provide insight into the histogenesis of GIST and the clinical behavior of this therapeutically responsive tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751374

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Gene expression studies on soft tissue tumors.

Authors:  Matt van de Rijn; Brian P Rubin
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  A knowledge framework for computational molecular-disease relationships in cancer.

Authors:  Michael N Cantor; Yves A Lussier
Journal:  Proc AMIA Symp       Date:  2002

3.  Coexpression analysis of human genes across many microarray data sets.

Authors:  Homin K Lee; Amy K Hsu; Jon Sajdak; Jie Qin; Paul Pavlidis
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

Review 4.  Role of gene expression arrays in sarcomas.

Authors:  Keith M Skubitz; Amy P N Skubitz
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

5.  Validation of computational methods in genomics.

Authors:  Edward R Doughtery; Hua Jianping; Michael L Bittner
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

Review 6.  Gastrointestinal stromal tumors.

Authors:  Maureen J O'Sullivan
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

Review 7.  An update on molecular genetics of gastrointestinal stromal tumours.

Authors:  L Tornillo; L M Terracciano
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

8.  Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP).

Authors:  David Vaudry; Yun Chen; Aurélia Ravni; Carol Hamelink; Abdel G Elkahloun; Lee E Eiden
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

9.  C-kit gene mutation in human gastrointestinal stromal tumors.

Authors:  Ying-Yong Hou; Yun-Shan Tan; Meng-Hong Sun; Yong-Kun Wei; Jian-Fang Xu; Shao-Hua Lu; Su-Jie A-Ke-Su; Yan-Nan Zhou; Feng Gao; Ai-Hua Zheng; Tai-Ming Zhang; Wen-Zhong Hou; Jian Wang; Xiang Du; Xiong-Zeng Zhu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

10.  Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.

Authors:  Ashlee V Moses; Michael A Jarvis; Camilo Raggo; Yolanda C Bell; Rebecca Ruhl; B G Mattias Luukkonen; Diana J Griffith; Cecily L Wait; Brian J Druker; Michael C Heinrich; Jay A Nelson; Klaus Früh
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.